Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastasis and improves survival: long-term follow-up of a randomized clinical trial.
Solsona
Eduardo
E
Instituto Valenciano de Oncología, Valencia, Spain. solsona@pulso.com